Aberrant neurofilament phosphorylation in Alzheimer disease.
about
Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTsPeptidyl-prolyl isomerase 1 regulates protein phosphatase 2A-mediated topographic phosphorylation of neurofilament proteinsMicrotubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer diseaseAbnormal processing of multiple proteins in Alzheimer disease.Aluminium maltol-induced neurocytoskeletal changes in fetal rabbit midbrain in matrix culture.Neuronal cytoskeletal lesions induced in the CNS by intraventricular and intravenous aluminium maltol in rabbits.Aluminum and Alzheimer's disease: perspectives for a cytoskeletal mechanism.Partial reversal of aluminium-induced neurofibrillary degeneration by desferrioxamine in adult male rabbits.Expression in cultured human neuroblastoma cells of epitopes associated with affected neurons in Alzheimer's disease.cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment.Alzheimer disease tangles share immunological similarities with multiphosphorylation repeats in the two large neurofilament proteinsRetinal ganglion cell loss in a rat ocular hypertension model is sectorial and involves early optic nerve axon loss.Attenuation of okadaic acid-induced hyperphosphorylation of cytoskeletal proteins by heat preconditioning and its possible underlying mechanisms.Processing of Alzheimer beta/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation.Tau pathology generated by overexpression of tau.Resolution and purification of a neurofilament-specific kinase.Topoisomerase I activity associated with human immunodeficiency virus (HIV) particles and equine infectious anemia virus core.Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.Declining phosphatases underlie aging-related hyperphosphorylation of neurofilaments.Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer's disease by iTRAQPhosphoproteomic analysis reveals site-specific changes in GFAP and NDRG2 phosphorylation in frontotemporal lobar degenerationActivation of a neurofilament kinase, a tau kinase, and a tau phosphatase by decreased ATP levels in nerve growth factor-differentiated PC-12 cells.Microtubule-associated protein tau as a therapeutic target in neurodegenerative disease.Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles.Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau proteinNeurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins.Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: a therapeutic targetCalpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's diseaseDegradation of proteins in the membrane-cytoskeleton complex in Alzheimer's disease. Might amyloidogenic APP processing be just the tip of the iceberg?Characterization of alternative routes for processing of the Alzheimer beta/A4-amyloid precursor protein. Differential effects of phorbol esters and chloroquine.Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins.Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau)Sigma-1 receptor regulates Tau phosphorylation and axon extension by shaping p35 turnover via myristic acid.A neuronal death model: overexpression of neuronal intermediate filament protein peripherin in PC12 cellsAge-related accumulation of amyloid inclusions in adrenal cortical cellsMolecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study.Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.Immune electron microscopic characterization of monoclonal antibodies to Alzheimer neurofibrillary tangles.Immunohistochemical and histopathologic correlates of Alzheimer's disease-associated Alz-50 immunoreactivity quantified in homogenates of cerebral tissueInhibition of Pin1 reduces glutamate-induced perikaryal accumulation of phosphorylated neurofilament-H in neurons.
P2860
Q24320601-85EFB697-150A-4F2F-BB78-F1F16D526AAAQ28567356-7FF97570-CA8E-4F57-8F57-DCB74E47365DQ29617285-C5E8EE28-0718-4F2D-A751-7392278FAC48Q30450830-41E74AAA-7AF6-4FF3-BEC0-B4F8702C5720Q30451149-80F85D7C-9AEA-4916-8A8E-48A1828C8589Q30452083-B2CF2EA0-105E-4488-8597-E98D16D64DFBQ30462285-68D8516E-3768-4A34-A8BA-49338F09289FQ30466649-284ACCB2-8CA2-469E-9264-9EFE4536F47CQ33254317-4EFDFFA4-408E-406C-BAF8-2FB77441BB7DQ33566923-7495360F-EE38-486F-97A9-6D1398BBDEE7Q33652987-5C99FC45-A6D1-4965-8BE1-D38D285B8A65Q33681832-9997046A-240B-440C-B7F6-FA0611B3F7EFQ33716854-51AE8F70-B505-4A81-825D-B36EFD609F8EQ33731523-CBEC9850-0EB5-42F0-9D17-C14DE2F09CC6Q33793293-FC1E72CC-7CA1-4774-AF7D-32F9F14728F4Q33833198-238763CC-C590-474D-97C3-858B926BD661Q33923420-53E2AA24-453E-4EEC-8AB7-DE1372232BC3Q33931836-A547E91C-55C9-4A5A-A6F4-AA5DD90818EEQ33937493-8C04B812-F691-4E91-9F9C-44FB97665FA0Q34281634-1BA37AF7-7405-4463-8569-DAFE4C5455D7Q34380573-445ED5D4-32A4-4B7B-A177-CC41503AC80FQ34546363-54F095B1-D15C-42B6-B61B-6342718508EDQ34610487-C68D46EA-3BDF-458E-879A-9AE93A03DE46Q34624758-F5127696-A27F-426B-ACCB-B8C829A3593BQ34624802-B5EF62E2-EE57-4217-8AC5-373F31A4DF33Q34722021-C367C8E8-CCDC-4346-978C-F81DF311AB63Q35016882-0A42B522-8168-47CA-BBBE-FD2479553757Q35103074-C60A72CC-BBAC-45EA-991D-19025D2A5084Q35186155-71194E8F-26C1-4836-BC12-92701EA236DDQ35277863-1116DA51-702A-4B1E-9FC4-4C9893BAA6ABQ35498406-6257EA6C-F4B8-4E0F-9AF9-61B76A5CFB00Q35609568-3C9CEB6C-92DB-47D3-B46A-EE4B28738746Q35669383-EA8858B2-B3A6-4006-8A86-0D278048824FQ35766384-04DDB190-6C06-4BA0-854D-F42189C6B75BQ35811141-8A97C89E-48E5-4CF5-80D6-D87119189E6BQ35811579-70244DA9-9099-4822-BDED-BC56125B93E1Q35811925-6A227116-EE36-4B13-A7A6-0DE35F48ADB3Q35831902-520AA15E-309D-41AC-9AEC-00B409869504Q35832353-88E450A6-BB50-49A8-A3B9-82A15D8F9AE9Q35949035-C5671F2E-6ABA-48C1-8447-9F44E5D74E24
P2860
Aberrant neurofilament phosphorylation in Alzheimer disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aberrant neurofilament phosphorylation in Alzheimer disease.
@en
Aberrant neurofilament phosphorylation in Alzheimer disease.
@nl
type
label
Aberrant neurofilament phosphorylation in Alzheimer disease.
@en
Aberrant neurofilament phosphorylation in Alzheimer disease.
@nl
prefLabel
Aberrant neurofilament phosphorylation in Alzheimer disease.
@en
Aberrant neurofilament phosphorylation in Alzheimer disease.
@nl
P2093
P2860
P356
P1476
Aberrant neurofilament phosphorylation in Alzheimer disease.
@en
P2093
L A Sternberger
N H Sternberger
P2860
P304
P356
10.1073/PNAS.82.12.4274
P407
P577
1985-06-01T00:00:00Z